Should Biogen Buy Alkermes? Post author:Sam Post published:February 27, 2018 Post category:BioPharma After a huge dry spell in M&A, 2018 is shaping up to be a great year for deal making. Source: BioSpace You Might Also Like Bay Area Avinger Cuts Workforce by 33% April 10, 2017 Health Insurer Cigna Paying $67 Billion to Buy Express Script March 7, 2018 Prometic Snags Rare Pediatric Disease Designation from the FDA for its Inter-Alpha-Inhibitor-Prot… March 4, 2018
Prometic Snags Rare Pediatric Disease Designation from the FDA for its Inter-Alpha-Inhibitor-Prot… March 4, 2018